The authors write a provocative response to the recent ACGME revisions to duty hours which extend the work hour limitation for first-year residents from 16 to 24hours. The authors also summarize data in favor of and against duty hour restrictions and emphasize the importance of relying on science when making education policy decisions.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
April 5, 2017
An international group of experts met at the 2017 STS Annual Meeting in Houston, Texas, to discuss the evolving practice of robotic and hybrid coronary revascularization.
April 3, 2017
This video shows a modified Bentall-De Bono procedure on a patient who had previously undergone repair for Tetralogy of Fallot.
March 30, 2017
A panel of experts met at the 2016 EACTS Annual Meeting to discuss the endovascular approach to descending thoracic aneurysms, including patient selection, surgical technique, and secondary open repair.
March 29, 2017
Steven Livesey of Southampton General Hospital, Southampton, UK, discusses the anatomy of Barlow's mitral valve and the options for correction.
March 29, 2017
A succinct editorial advancing the case for aortic super-centres
March 28, 2017
Vasoplegia was analysed in 225 patients undergoing heart failure surgery (left ventricular restoration, CorCap implantation or LVAD implantation). The complication was observed in 29% of patients.
March 28, 2017
Blood of septic or healthy pigs was used in a 12-h ECMO mock loop experiment. No higher activation of coagulation or inflammatory response or increased problems with the oxygenator was found with septic compared to control blood.
March 28, 2017
Christophe Chautems and colleagues shed light on the challenges, strategies and current developments in the field of magnetically driven medical microrobots for intracorporeal use.
March 28, 2017
The authors report here on the results of the Italian CHEETAH study, a randomized, double-blind, placebo-controlled trial examining whether adding the unique inotrope levosimendan—in low doses—improves 30-day mortality after cardiac surgery in patients with perioperative LV dysfunction.